We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[The analysis of diagnoses and pharmacological treatment of patients on disability pension due to depression].
Psychiatria Polska 2000 July
The aim of the study was to assess the diagnoses and pharmacological treatment in 80 patients with symptoms of depression in reference to the psychiatric examination due to disability pension proceedings. Diagnoses were often not in accordance with the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). Twenty two per cent of outpatients were treated using benzodiazepines only. In the group of antidepressants, mianserin, fluoxetine and doxepine were used most often (in 12%, 12% and 11% of outpatients respectively). Inpatients were usually treated with doxepine (24%) and mianserin (18%). As many as 15% of patients received benzodiazapines as the only drug during the hospitalisation. In contrast to the newer generation of drugs (moclobemide, fluoxetine), tricyclic antidepressants were usually used in low, not therapeutic doses. Further studies on the quality of treatment of depression in Poland, based on the more representative groups are necessary.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app